Coronary G-CSF injection did not promote the proliferation of distant organ cells or the increase of neovascularization, and no adverse reactions such as death, myocardial infarction and heart failure caused by coronary injection were found, which preliminarily proved that the method was safe and feasible. This evidence concerns the gene CSF3 and myocardial infarction.